Literature DB >> 27862678

Comparison of synchronous versus staged surgeries for patients with synchronous double cancers of the esophagus and head-and-neck.

Akira Matsumoto1, Masayuki Watanabe1, Shinji Mine1, Koujiro Nishida1, Hironobu Shigaki1, Kazuyoshi Kawabata2, Katsuhiko Yanaga3, Takeshi Sano1.   

Abstract

Esophageal and head and neck (H&N) cancers often occur synchronously, this study aimed to clarify the benefits and disadvantages of synchronous and staged operations for double H&N/esophagus cancers. We retrospectively reviewed 43 patients with synchronous double cancer of H&N and esophagus treated between July 2005 and July 2014, of whom 33 patients underwent synchronous operation (SYN) and 10 underwent staged operations (STG). We compared the short-term outcomes between the groups. Operation time was longer, amount of blood loss was larger, and hospital stay was longer in the SYN group than in each single surgery of the STG group. Incidence of postoperative complications did not differ between the groups. Tracheal necrosis was observed only in the SYN group. One patient died because of postoperative bleeding in the SYN group, whereas no mortality was seen in the STG group. Both the peripheral white blood cell counts and serum CRP levels during postoperative period were significantly higher in the SYN group than each single surgery of STG group. The staged surgery strategy for patients with synchronous esophagus/H&N cancers can attenuate surgical stress and thus may increase safety.
© 2016 International Society for Diseases of the Esophagus.

Entities:  

Keywords:  esophageal cancer; head and neck cancer; staged operation; synchronous operation

Mesh:

Year:  2017        PMID: 27862678     DOI: 10.1111/dote.12509

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  2 in total

1.  Treatment of Squamous Cell Carcinoma of the Esophagus Synchronously Associated with Head and Neck Cancer.

Authors:  Masaru Morita; Akinori Egashira; Y U Nakaji; Masaki Kagawa; Masahiko Sugiyama; Daisuke Yoshida; Mitsuhiko Ota; Masahiko Ikebe; Muneyuki Masuda; Yojiro Inoue; Naonobu Kunitake; Yasushi Toh
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

2.  Long-term treatment results and prognostic factors of synchronous and metachronous squamous cell carcinoma of head and neck and esophagus.

Authors:  Jiali Chen; Chunying Shen; Chaosu Hu; Cuihong Wang; Yongxue Zhu; Xueguan Lu
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.